Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Ezetimibe108 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46545 | 17723922 | Clin Liver Dis | Lipid-lowering agents that cause drug-induced hepatotoxicity. | 2007 | Details |
| A46654 | 16831521 | Med Hypotheses | Unexpected beneficial effect in the use of ezetimibe in non-alcoholic fatty liver disease. | 2006 | Details |
| A46660 | 16774486 | Expert Opin Drug Saf | Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease. Response to: Toth PP, Davidson MH: simvastatin and ezetimibe: combination therapy for the management of dyslipidaemia. Expert Opin. Pharmacother. (2005) 6(1):131-139. | 2006 | Details |
| A48253 | 18467918 | Eur J Gastroenterol Hepatol | Severe jaundice following treatment with ezetimibe. | 2008 | Details |
| A48999 | 21951423 | Hepatol Res | Therapeutic effects of ezetimibe for non-alcoholic steatohepatitis in fatty liver shionogi-ob/ob mice. | 2011 | Details |
| A49340 | 35783879 | Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. | 2022 | Details |
| A49485 | 35740238 | Biomedicines | Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50672 | 35307033 | BMC Med | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study). | 2022 | Details |